British Journal of Clinical Pharmacology · 1986 · 45 citations · 18 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyNeuropharmacologyPharmacodynamicsCardiac PharmacotherapyCardiovascular PharmacodynamicsDopaminergic PharmacologyHeart FailureHemodynamic PharmacologyInotropic TherapyCatecholamine InotropesHeart Failure PharmacologyHeart RateHemodynamic Drug EffectsInotropic RegulationMyocardial ChronotropyMyocardial InotropyVascular Resistance
Dopexamine increases inotropic state and rate of relaxation independent of changes in heart rate. Dopexamine has a chronotropic effect and results in a decrease in systemic vascular resistance. Dopexamine has a spectrum of action that should be useful in patients with severe heart failure.
18